Dr. Gareen focuses on cancer screening trials. She is interested in the downstream consequences of screening, including medical care utilization, iatrogenic consequences, changes in quality of life, and the impact of screening and screening results on smoking cessation.
Dr. Gareen also focuses on potential biases arising in cancer screening trials.
Dr. Gareen has a Ph.D. in Epidemiology from U.C.L.A. School of Public Health. She is interested in using epidemiologic methods to evaluate new medical technologies. She currently is working on evaluating lung cancer screening in the National Lung Cancer Screening Trial (NLST). In this trial she is responsible the abstraction of medical records to evaluate the downstream consequences of screening, changes in quality of life associated with screening and screening result, smoking, and assignment of cause of death.
ILANA GAREEN, PhD, University of California, Los Angeles, 1997
Are you Ilana Gareen? Click here to edit your research profile.